INTERNATIONAL PATENT: GENMAB A/S, BIONTECH SE FILES APPLICATION FOR "ANTIBODIES CAPABLE OF BINDING TO OX40 IN COMBINATION THERAPY"

GENEVA, June 10 -- GENMAB A/S (Carl Jacobsens Vej 302500 Valby), BIONTECH SE (An der Goldgrube 1255131 Mainz) filed a patent application (PCT/EP2024/084110) for "ANTIBODIES CAPABLE OF BINDING TO OX40 IN COMBINATION THERAPY" on Nov 29, 2024. With publication no. WO/2025/114541, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KEMPER, Kristel (3584 CT Utrecht), VAN DER KROEF, Maarten (3584 CT Utrecht), VERZIJL, Dennis (3584 CT Utrecht), GORLANI, Andrea (3584 CT Utrecht), DE GOEJE, Pauline Linda (3584 CT Utrecht), GUELEN, Lar...